Hypercoagulopathy in a hemodialysis patient:: Are elevations in factors VII and VIII effective?

被引：16

作者：

Baskin, E ^{[1
]}

Duman, Ö ^{[1
]}

Besbas, N ^{[1
]}

Ozen, S ^{[1
]}

机构：

[1] Univ Hacettepe, Dept Pediat Nephrol, TR-06100 Ankara, Turkey

来源：

NEPHRON | 1999年 / 83卷 / 02期

关键词：

D O I：

10.1159/000045504

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：180 / 180

页数：1

共 6 条

[1] INCREASED CARDIOVASCULAR RISK-FACTORS AND FEATURES OF ENDOTHELIAL ACTIVATION AND DYSFUNCTION IN DIALYZED UREMIC PATIENTS [J].

GRIS, JC ;

BRANGER, B ;

VECINA, F ;

ALSABADANI, B ;

FOURCADE, J ;

SCHVED, JF .

KIDNEY INTERNATIONAL, 1994, 46 (03) :807-813

[2] FACTOR VIP COAGULANT ACTIVITY AND ANTIGEN LEVELS IN HEALTHY-MEN ARE DETERMINED BY INTERACTION BETWEEN FACTOR-VII GENOTYPE AND PLASMA TRIGLYCERIDE CONCENTRATION [J].

HUMPHRIES, SE ;

LANE, A ;

GREEN, FR ;

COOPER, J ;

MILLER, GJ .

ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (02) :193-198

[3] Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype [J].

Irish, AB ;

Green, FR .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (03) :679-684

[4]

Ishii Y, 1996, NEPHRON, V73, P407

[5] INTERMITTENT HEPARIN TREATMENT DOES NOT INDUCE HYPER-COAGULABILITY IN HEMODIALYZED PATIENTS [J].

PUSINERI, F ;

BINI, A ;

MUSSONI, L ;

REMUZZI, G ;

DONATI, MB .

JOURNAL OF CLINICAL PATHOLOGY, 1980, 33 (07) :631-634

[6] BLOOD-COAGULATION, FIBRINOLYTIC, AND INHIBITORY PROTEINS IN END-STAGE RENAL-DISEASE - EFFECT OF HEMODIALYSIS [J].

VAZIRI, ND ;

GONZALES, EC ;

WANG, J ;

SAID, S .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (06) :828-835

← 1 →